Chemically, oxidative stress is associated with increased production of oxidizing species or a significant decrease in the effectiveness of antioxidant defenses, such as glutathione. The effects of oxidative stress depend upon the size of these changes, with a cell being able to overcome small perturbations and regain its original state. However, more severe oxidative stress can cause cell death, and even moderate oxidation can trigger apoptosis, while more intense stresses may cause necrosis.
Production of reactive oxygen species (ROS) is a particularly destructive aspect of oxidative stress. Such species include free radicals and peroxides. Some of the less reactive of these species (such as superoxide) can be converted by oxidoreduction reactions with transition metals or other redox cycling compounds (including quinones) into more aggressive radical species that can cause extensive cellular damage. Most long-term effects are caused by damage to DNA. DNA damage induced by ionizing radiation is similar to oxidative stress, and these lesions have been implicated in aging and cancer. Biological effects of single-base damage by radiation or oxidation, such as 8-oxoguanine and thymine glycol, have been extensively studied. Recently the focus has shifted to some of the more complex lesions. Tandem DNA lesions are formed at substantial frequency by ionizing radiation and metal-catalyzed H2O2 reactions. Under anoxic conditions, the predominant double-base lesion is a species in which C8 of guanine is linked to the 5-methyl group of an adjacent 3'-thymine (G[8,5- Me]T). Most of these oxygen-derived species are produced by normal aerobic metabolism. Normal cellular defense mechanisms destroy most of these. Repair of oxidative damages to DNA is frequent and ongoing, largely keeping up with newly induced damages. In rat urine, about 74,000 oxidative DNA adducts per cell are excreted daily. There is also a steady state level of oxidative damages in the DNA of a cell. There are about 24,000 oxidative DNA adducts per cell in young rats and 66,000 adducts per cell in old rats. Likewise, any damage to cells is constantly repaired. However, under the severe levels of oxidative stress that cause necrosis, the damage causes ATP depletion, preventing controlled apoptotic death and causing the cell to simply fall apart.
Polyunsaturated fatty acids, particularly arachidonic acid and linoleic acid, are primary targets for free radical and singlet oxygen oxidations. For example, in tissues and cells, the free radical oxidation of linoleic acid produces racemic mixtures of 13-hydroxy-9Z,11E-octadecadienoic acid, 13-hydroxy-9E,11E-octadecadienoic acid, 9-hydroxy-10E,12-E-octadecadienoic acid (9-EE-HODE), and 11-hydroxy-9Z,12-Z-octadecadienoic acid as well as 4-Hydroxynonenal while singlet oxygen attacks linoleic acid to produce (presumed but not yet proven to be racemic mixtures of) 13-hydroxy-9Z,11E-octadecadienoic acid, 9-hydroxy-10E,12-Z-octadecadienoic acid, 10-hydroxy-8E,12Z-octadecadienoic acid, and 12-hydroxy-9Z-13-E-octadecadienoic (see 13-Hydroxyoctadecadienoic acid and 9-Hydroxyoctadecadienoic acid). Similar attacks on arachidonic acid produce a far larger set of products including various isoprostanes, hydroperoxy- and hydroxy- eicosatetraenoates, and 4-hydroxyalkenals. While many of these products are used as markers of oxidative stress, the products derived from linoleic acid appear far more predominant than arachidonic acid products and therefore easier to identify and quantify in, for example, atheromatous plaques. Certain linoleic acid products have also been proposed to be markers for specific types of oxidative stress. For example, the presence of racemic 9-HODE and 9-EE-HODE mixtures reflects free radical oxidation of linoleic acid whereas the presence of racemic 10-hydroxy-8E,12Z-octadecadienoic acid and 12-hydroxy-9Z-13-E-octadecadienoic acid reflects singlet oxygen attack on linoleic acid. In addition to serving as markers, the linoleic and arachidonic acid products can contribute to tissue and/or DNA damage but also act as signals to stimulate pathways which function to combat oxidative stress.
One-electron reduction state of O 2, formed in many autoxidation reactions and by the electron transport chain. Rather unreactive but can release Fe2+ from iron-sulfur proteins and ferritin. Undergoes dismutation to form H 2O 2 spontaneously or by enzymatic catalysis and is a precursor for metal-catalyzed •OH formation.
Formed in a rapid reaction between •O− 2 and NO•. Lipid-soluble and similar in reactivity to hypochlorous acid. Protonation forms peroxynitrous acid, which can undergo homolytic cleavage to form hydroxyl radical and nitrogen dioxide.
One source of reactive oxygen under normal conditions in humans is the leakage of activated oxygen from mitochondria during oxidative phosphorylation. E. coli mutants that lack an active electron transport chain produce as much hydrogen peroxide as wild-type cells, indicating that other enzymes contribute the bulk of oxidants in these organisms. One possibility is that multiple redox-active flavoproteins all contribute a small portion to the overall production of oxidants under normal conditions.
Other enzymes capable of producing superoxide are xanthine oxidase, NADPH oxidases and cytochromes P450. Hydrogen peroxide is produced by a wide variety of enzymes including several oxidases. Reactive oxygen species play important roles in cell signalling, a process termed redox signaling. Thus, to maintain proper cellular homeostasis, a balance must be struck between reactive oxygen production and consumption.
The best studied cellular antioxidants are the enzymes superoxide dismutase (SOD), catalase, and glutathione peroxidase. Less well studied (but probably just as important) enzymatic antioxidants are the peroxiredoxins and the recently discovered sulfiredoxin. Other enzymes that have antioxidant properties (though this is not their primary role) include paraoxonase, glutathione-S transferases, and aldehyde dehydrogenases.
The amino acid methionine is prone to oxidation, but oxidized methionine can be reversible. Oxidation of methionine is shown to inhibit the phosphorylation of adjacent Ser/Thr/Tyr sites in proteins. This gives a plausible mechanism for cells to couple oxidative stress signals with cellular mainstream signaling such as phosphorylation.
Oxidative stress is thought to be linked to certain cardiovascular disease, since oxidation of LDL in the vascular endothelium is a precursor to plaque formation. Oxidative stress also plays a role in the ischemic cascade due to oxygen reperfusion injury following hypoxia. This cascade includes both strokes and heart attacks. Oxidative stress has also been implicated in chronic fatigue syndrome (ME/CFS). Oxidative stress also contributes to tissue injury following irradiation and hyperoxia, as well as in diabetes. In hematological cancers, such as leukemia, the impact of oxidative stress can be bilateral. Reactive oxygen species can disrupt the function of immune cells, promoting immune evasion of leukemic cells. On the other hand, high levels of oxidative stress can also be selectively toxic to cancer cells.
Oxidative stress is likely to be involved in age-related development of cancer. The reactive species produced in oxidative stress can cause direct damage to the DNA and are therefore mutagenic, and it may also suppress apoptosis and promote proliferation, invasiveness and metastasis. Infection by Helicobacter pylori which increases the production of reactive oxygen and nitrogen species in human stomach is also thought to be important in the development of gastric cancer.
Antioxidants as supplementsEdit
The use of antioxidants to prevent some diseases is controversial. In a high-risk group like smokers, high doses of beta carotene increased the rate of lung cancer since high doses of beta-carotene in conjunction of high oxygen tension due to smoking results in a pro-oxidant effect and an antioxidant effect when oxygen tension is not high. In less high-risk groups, the use of vitamin E appears to reduce the risk of heart disease. However, while consumption of food rich in vitamin E may reduce the risk of coronary heart disease in middle-aged to older men and women, using vitamin E supplements also appear to result in an increase in total mortality, heart failure, and hemorrhagic stroke. The American Heart Association therefore recommends the consumption of food rich in antioxidant vitamins and other nutrients, but does not recommend the use of vitamin E supplements to prevent cardiovascular disease. In other diseases, such as Alzheimer's, the evidence on vitamin E supplementation is also mixed. Since dietary sources contain a wider range of carotenoids and vitamin E tocopherols and tocotrienols from whole foods, ex post facto epidemiological studies can have differing conclusions than artificial experiments using isolated compounds. AstraZeneca's radical scavenging nitrone drug NXY-059 shows some efficacy in the treatment of stroke.
Oxidative stress (as formulated in Denham Harman's free-radical theory of aging) is also thought to contribute to the aging process. While there is good evidence to support this idea in model organisms such as Drosophila melanogaster and Caenorhabditis elegans, recent evidence from Michael Ristow's laboratory suggests that oxidative stress may also promote life expectancy of Caenorhabditis elegans by inducing a secondary response to initially increased levels of reactive oxygen species. The situation in mammals is even less clear. Recent epidemiological findings support the process of mitohormesis, however a 2007 meta-analysis indicating studies with a low risk of bias (randomization, blinding, follow-up) find that some popular antioxidant supplements (Vitamin A, Beta Carotene, and Vitamin E) may increase mortality risk (although studies more prone to bias reported the reverse).
The USDA removed the table showing the Oxygen Radical Absorbance Capacity (ORAC) of Selected Foods Release 2 (2010) table due to the lack of evidence that the antioxidant level present in a food translated into a related antioxidant effect in the body.
Metals such as iron, copper, chromium, vanadium, and cobalt are capable of redox cycling in which a single electron may be accepted or donated by the metal. This action catalyzes production of reactive radicals and ROS. The presence of such metals in biological systems in an uncomplexed form (not in a protein or other protective metal complex) can significantly increase the level of oxidative stress. These metals are thought to induce Fenton reactions and the Haber-Weiss reaction, in which hydroxyl radical is generated from hydrogen peroxide. The hydroxyl radical then can modify amino acids. For example, meta-tyrosine and ortho-tyrosine form by hydroxylation of phenylalanine. Other reactions include lipid peroxidation and oxidation of nucleobases. Metal-catalyzed oxidations also lead to irreversible modification of R (Arg), K (Lys), P (Pro) and T (Thr). Excessive oxidative-damage leads to protein degradation or aggregation.
The reaction of transition metals with proteins oxidated by ROS or RNS can yield reactive products that accumulate and contribute to aging and disease. For example, in Alzheimer's patients, peroxidized lipids and proteins accumulate in lysosomes of the brain cells.
Non-metal redox catalystsEdit
Certain organic compounds in addition to metal redox catalysts can also produce reactive oxygen species. One of the most important classes of these is the quinones. Quinones can redox cycle with their conjugate semiquinones and hydroquinones, in some cases catalyzing the production of superoxide from dioxygen or hydrogen peroxide from superoxide.
The immune system uses the lethal effects of oxidants by making the production of oxidizing species a central part of its mechanism of killing pathogens; with activated phagocytes producing both ROS and reactive nitrogen species. These include superoxide (•O− 2), nitric oxide (•NO) and their particularly reactive product, peroxynitrite (ONOO-). Although the use of these highly reactive compounds in the cytotoxic response of phagocytes causes damage to host tissues, the non-specificity of these oxidants is an advantage since they will damage almost every part of their target cell. This prevents a pathogen from escaping this part of immune response by mutation of a single molecular target.
In a rat model of premature aging, oxidative stress induced DNA damage in the neocortex and hippocampus was substantially higher than in normally aging control rats. Numerous studies have shown that the level of 8-OHdG, a product of oxidative stress, increases with age in the brain and muscle DNA of the mouse, rat, gerbil and human. Further information on the association of oxidative DNA damage with aging is presented in the article DNA damage theory of aging. However, it was recently shown that the fluoroquinolone antibiotic Enoxacin can diminish aging signals and promote lifespan extension in nematodes C. elegans by inducing oxidative stress.
Origin of eukaryotesEdit
The great oxygenation event began with the biologically induced appearance of oxygen in the Earth's atmosphere about 2.45 billion years ago. The rise of oxygen levels due to cyanobacterialphotosynthesis in ancient microenvironments was probably highly toxic to the surrounding biota. Under these conditions, the selective pressure of oxidative stress is thought to have driven the evolutionary transformation of an archaeal lineage into the first eukaryotes. Oxidative stress might have acted in synergy with other environmental stresses (such as ultraviolet radiation and/or desiccation) to drive this selection. Selective pressure for efficient repair of oxidative DNA damages may have promoted the evolution of eukaryotic sex involving such features as cell-cell fusions, cytoskeleton-mediated chromosome movements and emergence of the nuclear membrane. Thus, the evolution of meiotic sex and eukaryogenesis may have been inseparable processes that evolved in large part to facilitate repair of oxidative DNA damages.
COVID-19 and cardiovascular injuryEdit
It has been proposed that oxidative stress may play a major role to determine cardiac complications in COVID-19.
^Birnboin, H. C. (1986). "DNA strand breaks in human leukocytes induced by super-oxide anion, hydrogen peroxide and tumor promoters are repaired slowly compared to breaks induced by ionizing radiation". Carcinogenesis. 7 (9): 1511–1517. doi:10.1093/carcin/7.9.1511. PMID3017600.
^Joseph N, Zhang-James Y, Perl A, Faraone SV (November 2015). "Oxidative Stress and ADHD: A Meta-Analysis". J Atten Disord. 19 (11): 915–24. doi:10.1177/1087054713510354. PMC5293138. PMID24232168.
^ abHalliwell, Barry (2007). "Oxidative stress and cancer: have we moved forward?". Biochem. J. 401 (1): 1–11. doi:10.1042/BJ20061131. PMID17150040.
^Hwang O (March 2013). "Role of oxidative stress in Parkinson's disease". Exp Neurobiol. 22 (1): 11–7. doi:10.5607/en.2013.22.1.11. PMC3620453. PMID23585717.
^Romá-Mateo C, Aguado C, García-Giménez JL, Ibáñez-Cabellos JS, Seco-Cervera M, Pallardó FV, Knecht E, Sanz P (2015). "Increased oxidative stress and impaired antioxidant response in Lafora disease". Mol. Neurobiol. 51 (3): 932–46. doi:10.1007/s12035-014-8747-0. hdl:10261/123869. PMID24838580. S2CID 13096853.
^Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007). "Free radicals and antioxidants in normal physiological functions and human disease". Int. J. Biochem. Cell Biol. 39 (1): 44–84. doi:10.1016/j.biocel.2006.07.001. PMID16978905.
^Bonomini F, Tengattini S, Fabiano A, Bianchi R, Rezzani R (March 2008). "Atherosclerosis and oxidative stress". Histol. Histopathol. 23 (3): 381–90. doi:10.14670/HH-23.381. PMID18072094.
^Ramond A, Godin-Ribuot D, Ribuot C, Totoson P, Koritchneva I, Cachot S, Levy P, Joyeux-Faure M (June 2013). "Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia". Fundam Clin Pharmacol. 27 (3): 252–61. doi:10.1111/j.1472-8206.2011.01015.x. PMID22145601. S2CID 40420948.
^Dean OM, van den Buuse M, Berk M, Copolov DL, Mavros C, Bush AI (July 2011). "N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and D-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder". Neurosci. Lett. 499 (3): 149–53. doi:10.1016/j.neulet.2011.05.027. PMID21621586. S2CID 32986064.
^de Diego-Otero Y, Romero-Zerbo Y, el Bekay R, Decara J, Sanchez L, Rodriguez-de Fonseca F, del Arco-Herrera I (March 2009). "Alpha-tocopherol protects against oxidative stress in the fragile X knockout mouse: an experimental therapeutic approach for the Fmr1 deficiency". Neuropsychopharmacology. 34 (4): 1011–26. doi:10.1038/npp.2008.152. PMID18843266.
^Amer J, Ghoti H, Rachmilewitz E, Koren A, Levin C, Fibach E (January 2006). "Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants". Br. J. Haematol. 132 (1): 108–13. doi:10.1111/j.1365-2141.2005.05834.x. PMID16371026.
^Aly DG, Shahin RS (2010). "Oxidative stress in lichen planus". Acta Dermatovenerol Alp Pannonica Adriat. 19 (1): 3–11. PMID20372767.
^Arican O, Kurutas EB (March 2008). "Oxidative stress in the blood of patients with active localized vitiligo". Acta Dermatovenerol Alp Pannonica Adriat. 17 (1): 12–6. PMID18454264.
^James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (December 2004). "Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism". Am. J. Clin. Nutr. 80 (6): 1611–7. doi:10.1093/ajcn/80.6.1611. PMID15585776.
^Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ (September 2005). "Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms". Free Radic. Biol. Med. 39 (5): 584–9. doi:10.1016/j.freeradbiomed.2005.04.020. PMID16085177.
^Jiménez-Fernández S, Gurpegui M, Díaz-Atienza F, Pérez-Costillas L, Gerstenberg M, Correll CU (December 2015). "Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis". J Clin Psychiatry. 76 (12): 1658–67. doi:10.4088/JCP.14r09179. PMID26579881.
^Gems D, Partridge L (March 2008). "Stress-response hormesis and aging: "that which does not kill us makes us stronger"". Cell Metab. 7 (3): 200–3. doi:10.1016/j.cmet.2008.01.001. PMID18316025.
^Waszczak, Cezary; Carmody, Melanie; Kangasjärvi, Jaakko (2018-04-29). "Reactive Oxygen Species in Plant Signaling". Annual Review of Plant Biology. 69 (1): 209–236. doi:10.1146/annurev-arplant-042817-040322. ISSN 1543-5008.
^Schafer FQ, Buettner GR (2001). "Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple". Free Radic. Biol. Med. 30 (11): 1191–212. doi:10.1016/S0891-5849(01)00480-4. PMID11368918.
^Lennon SV, Martin SJ, Cotter TG (1991). "Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli". Cell Prolif. 24 (2): 203–14. doi:10.1111/j.1365-2184.1991.tb01150.x. PMID2009322. S2CID 37720004.
^Evans MD, Cooke MS (May 2004). "Factors contributing to the outcome of oxidative damage to nucleic acids". BioEssays. 26 (5): 533–42. doi:10.1002/bies.20027. PMID15112233. S2CID 11714476.
^LC Colis; P Raychaudhury; AK Basu (2008). "Mutational specificity of gamma-radiation-induced guanine-thymine and thymine-guanine intrastrand cross-links in mammalian cells and translesion synthesis past the guanine-thymine lesion by human DNA polymerase eta". Biochemistry. 47 (6): 8070–9. doi:10.1021/bi800529f. PMC2646719. PMID18616294.
^ abHelbock HJ, Beckman KB, Shigenaga MK, Walter PB, Woodall AA, Yeo HC, Ames BN (January 1998). "DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine". Proc. Natl. Acad. Sci. U.S.A. 95 (1): 288–93. Bibcode:1998PNAS...95..288H. doi:10.1073/pnas.95.1.288. PMC18204. PMID9419368.
^Lelli JL, Becks LL, Dabrowska MI, Hinshaw DB (1998). "ATP converts necrosis to apoptosis in oxidant-injured endothelial cells". Free Radic. Biol. Med. 25 (6): 694–702. doi:10.1016/S0891-5849(98)00107-5. PMID9801070.
^Lee YJ, Shacter E (1999). "Oxidative stress inhibits apoptosis in human lymphoma cells". J. Biol. Chem. 274 (28): 19792–8. doi:10.1074/jbc.274.28.19792. PMID10391922.
^ abAkazawa-Ogawa Y, Shichiri M, Nishio K, Yoshida Y, Niki E, Hagihara Y (February 2015). "Singlet-oxygen-derived products from linoleate activate Nrf2 signaling in skin cells". Free Radic. Biol. Med. 79: 164–75. doi:10.1016/j.freeradbiomed.2014.12.004. PMID25499849.
^ abcRiahi Y, Cohen G, Shamni O, Sasson S (2010). "Signaling and cytotoxic functions of 4-hydroxyalkenals". Am J Physiol Endocrinol Metab. 299 (6): E879–86. doi:10.1152/ajpendo.00508.2010. PMID20858748.
^ abYoshida Y (2015). "Chemistry of Lipid Peroxidation Products and Their Use as Biomarkers in Early Detection of Diseases". Journal of Oleo Science. 64 (4): 347–356. doi:10.5650/jos.ess14281. PMID25766928.
^Vigor C, Bertrand-Michel J, Pinot E, Oger C, Vercauteren J, Le Faouder P, Galano JM, Lee JC, Durand T (August 2014). "Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids" (PDF). J. Chromatogr. B. 964: 65–78. doi:10.1016/j.jchromb.2014.04.042. PMID24856297.
^Waddington EI, Croft KD, Sienuarine K, Latham B, Puddey IB (March 2003). "Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates". Atherosclerosis. 167 (1): 111–20. doi:10.1016/S0021-9150(02)00391-X. PMID12618275.
^Cho KJ, Seo JM, Kim JH (July 2011). "Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species". Mol. Cells. 32 (1): 1–5. doi:10.1007/s10059-011-1021-7. PMC3887656. PMID21424583.
^Galano JM, Mas E, Barden A, Mori TA, Signorini C, De Felice C, Barrett A, Opere C, Pinot E, Schwedhelm E, Benndorf R, Roy J, Le Guennec JY, Oger C, Durand T (2013). "Isoprostanes and neuroprostanes: Total synthesis, biological activity and biomarkers of oxidative stress in humans" (PDF). Prostaglandins Other Lipid Mediat. 107: 95–102. doi:10.1016/j.prostaglandins.2013.04.003. PMID23644158.
^Cohen G, Riahi Y, Sunda V, Deplano S, Chatgilialoglu C, Ferreri C, Kaiser N, Sasson S (2013). "Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes". Free Radic Biol Med. 65: 978–87. doi:10.1016/j.freeradbiomed.2013.08.163. PMID23973638.
^Speed N, Blair IA (December 2011). "Cyclooxygenase- and lipoxygenase-mediated DNA damage". Cancer Metastasis Rev. 30 (3–4): 437–47. doi:10.1007/s10555-011-9298-8. PMC3237763. PMID22009064.
^Sies, H. (1985). "Oxidative stress: introductory remarks". In H. Sies (ed.). Oxidative Stress. London: Academic Press. pp. 1–7.
^Docampo, R. (1995). "Antioxidant mechanisms". In J. Marr; M. Müller (eds.). Biochemistry and Molecular Biology of Parasites. London: Academic Press. pp. 147–160.
^ abRice-Evans CA, Gopinathan V (1995). "Oxygen toxicity, free radicals and antioxidants in human disease: biochemical implications in atherosclerosis and the problems of premature neonates". Essays Biochem. 29: 39–63. PMID9189713.
^Seaver LC, Imlay JA (November 2004). "Are respiratory enzymes the primary sources of intracellular hydrogen peroxide?". J. Biol. Chem. 279 (47): 48742–50. doi:10.1074/jbc.M408754200. PMID15361522.
^Messner KR, Imlay JA (November 2002). "Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase". J. Biol. Chem. 277 (45): 42563–71. doi:10.1074/jbc.M204958200. PMID12200425.
^Imlay JA (2003). "Pathways of oxidative damage". Annu. Rev. Microbiol. 57 (1): 395–418. doi:10.1146/annurev.micro.57.030502.090938. PMID14527285.
^Hardin SC, Larue CT, Oh MH, Jain V, Huber SC (August 2009). "Coupling oxidative signals to protein phosphorylation via methionine oxidation in Arabidopsis". Biochem. J. 422 (2): 305–12. doi:10.1042/BJ20090764. PMC2782308. PMID19527223.
^Hollis F, Kanellopoulos AK, Bagni C (August 2017). "Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives". Current Opinion in Neurobiology. 45: 178–187. doi:10.1016/j.conb.2017.05.018. PMID28628841. S2CID 3617876.
^Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA (July 2006). "Involvement of oxidative stress in Alzheimer disease". J. Neuropathol. Exp. Neurol. 65 (7): 631–41. doi:10.1097/01.jnen.0000228136.58062.bf. PMID16825950.
^Bošković M, Vovk T, Kores Plesničar B, Grabnar I (June 2011). "Oxidative stress in schizophrenia". Curr Neuropharmacol. 9 (2): 301–12. doi:10.2174/157015911795596595. PMC3131721. PMID22131939.
^Ramalingam M, Kim SJ (August 2012). "Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases". J Neural Transm (Vienna). 119 (8): 891–910. doi:10.1007/s00702-011-0758-7. PMID22212484. S2CID 2615132.
^Nijs J, Meeus M, De Meirleir K (2006). "Chronic musculoskeletal pain in chronic fatigue syndrome: recent developments and therapeutic implications". Man Ther. 11 (3): 187–91. doi:10.1016/j.math.2006.03.008. PMID16781183.
^Krzysztof D, Agnieszka G, Malgorzata F (2020). "cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies". Frontiers in Immunology. 11: 1538. doi:10.3389/fimmu.2020.01538. PMC7385186. PMID32793211.
^Udensi UK, Tchounwou PB (2014). "Dual effect of oxidative stress on leukemia cancer induction and treatment". J Exp Clin Cancer Res. 33: 106. doi:10.1186/s13046-014-0106-5. PMC4320640. PMID25519934.
^Handa O, Naito Y, Yoshikawa T (2011). "Redox biology and gastric carcinogenesis: the role of Helicobacter pylori". Redox Rep. 16 (1): 1–7. doi:10.1179/174329211X12968219310756. PMC6837368. PMID21605492.
^Meyers DG, Maloley PA, Weeks D (1996). "Safety of antioxidant vitamins". Arch. Intern. Med. 156 (9): 925–35. doi:10.1001/archinte.156.9.925. PMID8624173.
^Ruano-Ravina A, Figueiras A, Freire-Garabal M, Barros-Dios JM (2006). "Antioxidant vitamins and risk of lung cancer". Curr. Pharm. Des. 12 (5): 599–613. doi:10.2174/138161206775474396. PMID16472151.
^Zhang P, Omaye ST (February 2001). "Antioxidant and prooxidant roles for beta-carotene, alpha-tocopherol and ascorbic acid in human lung cells". Toxicol in Vitro. 15 (1): 13–24. doi:10.1016/S0887-2333(00)00054-0. PMID11259865.
^Pryor WA (2000). "Vitamin E and heart disease: basic science to clinical intervention trials". Free Radic. Biol. Med. 28 (1): 141–64. doi:10.1016/S0891-5849(99)00224-5. PMID10656300.
^Saremi A, Arora R (2010). "Vitamin E and cardiovascular disease". Am J Ther. 17 (3): e56–65. doi:10.1097/MJT.0b013e31819cdc9a. PMID19451807. S2CID 25631305.
^Boothby LA, Doering PL (2005). "Vitamin C and vitamin E for Alzheimer's disease". Ann Pharmacother. 39 (12): 2073–80. doi:10.1345/aph.1E495. PMID16227450. S2CID 46645284.
^Kontush K, Schekatolina S (2004). "Vitamin E in neurodegenerative disorders: Alzheimer's disease". Ann. N. Y. Acad. Sci. 1031 (1): 249–62. Bibcode:2004NYASA1031..249K. doi:10.1196/annals.1331.025. PMID15753151. S2CID 33556198.
^Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007). "Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis". JAMA. 297 (8): 842–57. doi:10.1001/jama.297.8.842. PMID17327526.. See also the letter Archived 2008-07-24 at the Wayback Machine to JAMA by Philip Taylor and Sanford Dawsey and the reply Archived 2008-06-24 at the Wayback Machine by the authors of the original paper.
^*Pratviel, Genevieve (2012). "Chapter 7. Oxidative DNA Damage Mediated by Transition Metal Ions and Their Complexes". In Astrid Sigel, Helmut Sigel and Roland K. O. Sigel (ed.). Interplay between Metal Ions and Nucleic Acids. Metal Ions in Life Sciences. Vol. 10. Springer. pp. 201–216. doi:10.1007/978-94-007-2172-2_7. ISBN 978-94-007-2171-5. PMID22210340.
^Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A (2006). "Protein carbonylation, cellular dysfunction, and disease progression". J. Cell. Mol. Med. 10 (2): 389–406. doi:10.1111/j.1582-4934.2006.tb00407.x. PMC3933129. PMID16796807.
^Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA (August 2008). "Oxidative stress and covalent modification of protein with bioactive aldehydes". J. Biol. Chem. 283 (32): 21837–41. doi:10.1074/jbc.R700019200. PMC2494933. PMID18445586.
^Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD (October 2004). "Free radicals and antioxidants in human health: current status and future prospects". J Assoc Physicians India. 52: 794–804. PMID15909857.
^Nathan C, Shiloh MU (2000). "Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens". Proc. Natl. Acad. Sci. U.S.A. 97 (16): 8841–8. Bibcode:2000PNAS...97.8841N. doi:10.1073/pnas.97.16.8841. PMC34021. PMID10922044.
^ abWright C, Milne S, Leeson H (June 2014). "Sperm DNA damage caused by oxidative stress: modifiable clinical, lifestyle and nutritional factors in male infertility". Reprod. Biomed. Online. 28 (6): 684–703. doi:10.1016/j.rbmo.2014.02.004. PMID24745838.
^Guz J, Gackowski D, Foksinski M, Rozalski R, Zarakowska E, Siomek A, Szpila A, Kotzbach M, Kotzbach R, Olinski R (2013). "Comparison of oxidative stress/DNA damage in semen and blood of fertile and infertile men". PLOS ONE. 8 (7): e68490. Bibcode:2013PLoSO...868490G. doi:10.1371/journal.pone.0068490. PMC3709910. PMID23874641.
^Sinha JK, Ghosh S, Swain U, Giridharan NV, Raghunath M (June 2014). "Increased macromolecular damage due to oxidative stress in the neocortex and hippocampus of WNIN/Ob, a novel rat model of premature aging". Neuroscience. 269: 256–64. doi:10.1016/j.neuroscience.2014.03.040. PMID24709042. S2CID 9934178.
^Bernstein H, Payne CM, Bernstein C, Garewal H, Dvorak K (2008). Cancer and aging as consequences of un-repaired DNA damage. In: New Research on DNA Damages (Editors: Honoka Kimura and Aoi Suzuki) Nova Science Publishers, Inc., New York, Chapter 1, pp. 1–47. open access, but read only "Cancer and Aging as Consequences of Un-Repaired DNA Damage". Archived from the original on 2014-10-25. Retrieved 2014-11-14. ISBN 1604565810 ISBN 978-1604565812
^Pinto S, Sato VN, De-Souza EA, Ferraz RC, Camara H, Pinca AF, Mazzotti DR, Lovci MT, Tonon G, Lopes-Ramos CM, Parmigiani RB, Wurtele M, Massirer KB, Mori MA (September 2018). "Enoxacin extends lifespan of C. elegans by inhibiting miR-34-5p and promoting mitohormesis". Redox Biol. 18: 84–92. doi:10.1016/j.redox.2018.06.006. PMC6037660. PMID29986212.
^ abcGross J, Bhattacharya D (August 2010). "Uniting sex and eukaryote origins in an emerging oxygenic world". Biol. Direct. 5: 53. doi:10.1186/1745-6150-5-53. PMC2933680. PMID20731852.
^Bernstein H, Bernstein C. Sexual communication in archaea, the precursor to meiosis. pp. 103-117 in Biocommunication of Archaea (Guenther Witzany, ed.) 2017. Springer International Publishing ISBN 978-3-319-65535-2 DOI 10.1007/978-3-319-65536-9
^Hörandl E, Speijer D (February 2018). "How oxygen gave rise to eukaryotic sex". Proc. Biol. Sci. 285 (1872): 20172706. doi:10.1098/rspb.2017.2706. PMC5829205. PMID29436502.
^Loffredo, Lorenzo; Violi, Francesco (August 2020). "COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?". International Journal of Cardiology. 312: 136. doi:10.1016/j.ijcard.2020.04.066. PMC7833193. PMID32505331.